Compare ABEO & VREX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ABEO | VREX |
|---|---|---|
| Founded | 1974 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 399.5M | 447.2M |
| IPO Year | 2005 | 2016 |
| Metric | ABEO | VREX |
|---|---|---|
| Price | $6.35 | $18.50 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 3 |
| Target Price | ★ $20.00 | $16.67 |
| AVG Volume (30 Days) | ★ 1.2M | 1.1M |
| Earning Date | 05-13-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 165.16 | N/A |
| EPS | N/A | ★ 0.23 |
| Revenue | $2,998,000.00 | ★ $811,000,000.00 |
| Revenue This Year | $1,024.31 | $5.35 |
| Revenue Next Year | $145.42 | $3.88 |
| P/E Ratio | ★ N/A | $80.22 |
| Revenue Growth | ★ 258.18 | N/A |
| 52 Week Low | $4.00 | $9.09 |
| 52 Week High | $7.65 | $18.63 |
| Indicator | ABEO | VREX |
|---|---|---|
| Relative Strength Index (RSI) | 44.05 | 90.84 |
| Support Level | $4.94 | $9.73 |
| Resistance Level | $7.36 | N/A |
| Average True Range (ATR) | 0.31 | 0.36 |
| MACD | 0.02 | 0.82 |
| Stochastic Oscillator | 26.37 | 98.33 |
Abeona Therapeutics Inc is a commercial-stage biopharmaceutical company. The company is focused on developing cell and gene therapies for life-threatening diseases. The company's ZEVASKYN (prademagene zamikeracel) is an autologous cell-based gene therapy for the treatment of wounds in adults and pediatric patients with recessive dystrophic epidermolysis bullosa (RDEB). The company's development portfolio includes adeno-associated virus (AAV)-based gene therapies for ophthalmic diseases with high unmet medical need.
Varex Imaging Corp Designs, manufactures, sells, and services X-ray imaging components, including X-ray tubes, detectors, ionization chambers, high-voltage connectors, software, collimators, generators, exposure control devices, and heat exchangers.. The company operates through two segments: Medical, the key revenue driver, providing X-ray imaging components and accessories for healthcare applications, and Industrial, which provides Linatron X-ray accelerators, X-ray tubes, flat panel detectors, high-voltage connectors, and coolers for non-medical use. Geographically, it generates the majority of its revenue from Europe, the Middle East, and Africa (EMEA), with the rest coming from the Americas and Asia Pacific.